For the first time, an international analysis has shown that when people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.…

Read more

Read more

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland

Threshold:                          UVgO
Running time:                    November 2025
Reason for procurement: …

Read more

Verhandlungsverfahren ohne Teilnahmewettbewerb

Read more

Verhandlungsverfahren ohne Teilnahmewettbewerb

Read more

Verhandlungsverfahren ohne Teilnahmewettbewerb

Read more

A research team at Helmholtz Munich has uncovered a previously unknown “cool-down” signal within body fat. Led by PD Dr. John Heiker and Inka Rapöhn from the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) at Helmholtz…

Read more

The European Commission has appointed Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, to the Scientific Council of the European Research Council (ERC). Alongside five newly selected members, she will…

Read more

Dr. Jian Cui, principal investigator at the Helmholtz Pioneer Campus, has been awarded an ERC Consolidator Grant for his project PhotonSignaling. As part of Helmholtz Munich’s innovation hub, Cui belongs to a generation of “Pioneers” turning bold…

Read more

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Read more

Dr. Raffaele Teperino, Principal Investigator of the Environmental Epigenetics Group at Helmholtz Munich, has been honored with the PRO-SCIENTIA Award 2025 of the Eckhart-Buddecke Foundation. The award, endowed with 10,000 euros, recognizes…

Read more

Researchers at Helmholtz Munich have found that the body begins signaling the risk of type 2 diabetes many years before the disease is diagnosed. In a long-term study, the team examined hundreds of blood metabolites – small molecules that reflect…

Read more

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides the first molecular…

Read more

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS allows scientists to profile where proteins and…

Read more

Prof. Maria-Elena Torres-Padilla, this year’s Leibniz Prize winner, has received the Bavarian Maximiliansorden for Science and Art. Minister-President Dr. Markus Söder presented the distinguished state honor to her at the State Chancellery,…

Read more

According to the World Health Organization, around 300 million people worldwide suffer from genetic disorders – and for most of them, no effective treatments exist. A research team at the Institute of Stem Cell Research at Helmholtz Munich is…

Read more

Helmholtz Munich is part of the EU research initiative PROBE, which aims to fundamentally transform the way osteoarthritis is diagnosed and treated. The project is funded through HORIZON EUROPE by the Innovative Health Initiative and has a total…

Read more

The Helmholtz Munich Talent Forum took place on November 18–19, 2025, at the Helmholtz Munich Conference Center, bringing together eight outstanding early-career scientists from around the world working in the fields of Epigenetics and Nucleic Acids…

Read more

Dr. Eric Wenzel, Clinician Scientist at the Leipzig University and the Helmholtz Institute for Metabolism, Obesity, and Vascular Research (HI-MAG) of Helmholtz Munich and the Medical Faculty of Leipzig University, has been awarded the Jürgen-Bierich…

Read more

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

Read more

The European Respiratory Society (ERS) and COPD-iNET Research Symposium in Prague brought together more than 120 clinicians, researchers, and patient advocates to address one of the most pressing challenges in respiratory medicine: Chronic…

Read more

World COPD Day aims to raise awareness, share knowledge, and promote action to reduce the global burden of chronic obstructive pulmonary disease (COPD). Helmholtz Munich is driving progress in these efforts, with pioneering research on new…

Read more

A new study reveals how two key molecular players – the linear ubiquitin chain assembly complex (LUBAC) and TRAF6 – work together to fine-tune immune signaling in T cells. Published in Nature Communications, the research from the group of Prof.…

Read more

NAKO, the German National Cohort, will play a key role in the National Decade on "Post-Infectious Diseases", initiated by the German Federal Ministry of Research, Technology, and Space (BMFTR). Building on its years of foundational work, NAKO…

Read more

Diabetes affects millions worldwide, but research is opening new paths for better prevention, treatment, and ultimately, a cure. Helmholtz Munich is at the forefront of these efforts, advancing science to combat diabetes and related metabolic…

Read more

An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state – even before prediabetes. Affected individuals respond particularly well to lifestyle interventions. This value could become a…

Read more

First results of the Primary Oral Insulin Trial (POInT) mark an important step towards the prevention of type 1 diabetes, pointing future efforts to personalized strategies. The group led by researchers from Helmholtz Munich and the Technical…

Read more

Scientists at Helmholtz Munich, together with Harvard Medical School and international collaborators, have developed TITAN, an artificial intelligence (AI) model capable of analyzing and describing digital pathology slides. By combining information…

Read more

How do biomolecules breathe? This question guided the recent international symposium “Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies”, hosted by the Bavarian NMR Center (BNMRZ), a joint infrastructure of Helmholtz Munich…

Read more

When nanoparticles enter the lungs, the immune system reacts within minutes. Researchers from the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich have now revealed how alveolar macrophages – immune cells located in the lung’s air sacs…

Read more